Limited coverage criteria – eslicarbazepine acetate

Last updated on May 20, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	eslicarbazepine acetate
Strength & form	200 mg, 400 mg, 600 mg, 800 mg tablet

Special Authority criteria	Approval period
For the treatment of partial-onset seizures in adults and to be used: As adjunctive therapy (used in combination with at least ONE other anti-epileptic drug) AND After at least FOUR other anti-epileptic medications have been tried without success (names of previously tried therapies and response must be indicated on the Special Authority request)	Indefinite

Special Authority criteria

Approval period

For the treatment of partial-onset seizures in adults and to be used:

As adjunctive therapy (used in combination with at least ONE other anti-epileptic drug)

AND

After at least FOUR other anti-epileptic medications have been tried without success (names of previously tried therapies and response must be indicated on the Special Authority request)

Indefinite

Practitioner exemptions

None

Special notes

Special Authority requests should include documentation stating which other anti-epileptic drugs have been tried in adequate doses. Examples of other anti-epileptic drugs may include:
- Carbamazepine
- Clobazam
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Phenytoin
- Topiramate
- Vigabatrin
- Valproic acid

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics